No, it wouldn't be that far back since they had plenty of shares to burn through. Maybe after they moved to the OTC?? I forget what year that was. Actually my rs calls are very accurate with the handful of biotechs I watch.
Given management's older age, I could easily see one last reverse split and a move to the private sector.
Market Data 
Markets 
AI
